Home Open Access News Health & Social Care News

Health & Social Care News

clean air

School children exposed to 30% more toxic pollution than adults while walking to school

New research by Global Action Plan, coinciding with this year's Clean Air Day, 21 June, found that primary and nursery school children were being exposed to 30% more toxic pollution compared to adults when walking along busy roads
air quality

Air matters… everywhere! Why our lungs need good quality air indoors

Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explains why air matters, for everybody, everywhere (H2)
diabetes prevention

NHS England Diabetes Prevention Programme

NHS England’s Diabetes Prevention Programme is placed under the spotlight by Open Access Government 
the NHS

Positioning the NHS: the good and the bad

Over the last few years, it has been discovered that too many patients are being treated as if they were emergencies. Is it all bad for the organisation though? Join Tilly Bailey & Irvine Law Firm as they weigh up both the positive and negative aspects of the NHS
NHS

NHS to benefit from £20.5 billion funding boost over the next 5 years

The Prime Minister has announced that the NHS will receive increased funding of £20.5 billion per year by the end of five years
paediatric cancer

The role of collaboration in tackling paediatric cancer

Prof. Martin Schrappe, President of the European Society for Paediatric Oncology details the vital role of collaboration in tackling paediatric cancer across Europe
health data

Turning health data into knowledge to improve lives

Amanda White, Director of Communications and Marketing at Health Data Research UK, reflects on the opportunities to harness the UK’s strengths in data science to transform health 
tuberculosis vaccine

The current status of tuberculosis vaccine development

Helen McShane, Professor of Vaccinology at The Jenner Institute, University of Oxford reveals the current status of tuberculosis vaccine development in the world today.
muscular dystrophy

The key issues around muscular dystrophy (MD) in Europe

Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today 
healthcare technology

An update on exports in the health technology sector

Jonathan Evans, communications manager at the Association of British HealthTech Industries provides an interesting update on the health technology sector, including the extent to which the UK exports to the EU every year in this vein.
human health

Nanomedicines: Depicting human health risks hindering clinical translation

Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.
developmental biology

How developmental biology changes our lives

Shyh-Jye Lee (Jeff), Ph. D, President of the Taiwanese Society of Developmental Biology (TSDB) explains the way in which developmental biology impacts upon our lives
Muscular dystrophy

Muscular dystrophy: Present concerns and foreseen opportunities

Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
mental health care

Mental health care and the pharmaceutical industry

Marcin Rodzinka, Project Coordinator at Mental Health Europe explains how transparency between the pharma industry and health professionals can influence the quality of mental health care in Europe today
curing cancer

The challenge of curing cancer in the world’s children

Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children
therapeutic intervention

What’s in an aggregate? Therapeutic intervention in Huntington’s

Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention
speech, language and communication needs

What next for children and young people with speech, language and communication needs?

Mary Hartshorne, I CAN’s Head of Evidence shares her thoughts on the report Bercow: Ten Years On and the next steps for children and young people with speech, language and communication needs
commercialisation

The challenge of commercialisation: Keeping an academic balance

Prof Colin J Suckling OBE DSc FRSE, research professor of chemistry at the University of Strathclyde’s Department of Pure & Applied Chemistry shares his views on the challenge of commercialisation when it comes to research into medicinal chemistry
therapies for Huntington’s disease

Sources of funding in the development of therapies for Huntington’s disease

Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
root cause of Type 2 diabetes

Tackling the root cause of Type 2 diabetes: Obesity

Kristoffer From, CEO of Liva Healthcare and Simon Pickup, UK Managing Director at Liva Healthcare share their thoughts on why obesity is key to tackling the root cause of Type 2 diabetes

Healthcare Reports

Healthcare eBooks